Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection

Zhiyuan He,Yulin Ma,Sirui Yang,Shuyuan Zhang,Shuai Liu,Jianxin Xiao,Yajing Wang,Wei Wang,Hongjian Yang,Shengli Li,Zhijun Cao
DOI: https://doi.org/10.1186/s40168-022-01269-0
IF: 15.5
2022-05-29
Microbiome
Abstract:Antimicrobials are often used to prevent and treat diarrhea induced by enteroaggregative Escherichia coli (EAEC) in young ruminants. However, drug overuse or misuse accelerates the spread of multidrug-resistant extended-spectrum β-lactamase (ESBL)-producing E. coli . Thus, supplementary foods as alternatives to antibiotics are needed to prevent colibacillus diarrhea in neonatal dairy calves. Ursodeoxycholic acid (UDCA), a therapeutic bile acid, helps alleviate colitis. However, how UDCA helps alleviate ESBL-EAEC-induced clinical symptoms and colitis remains unclear.
microbiology
What problem does this paper attempt to address?